ArticleJournal of experimental & clinical cancer research : CR2020

A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.

Alessia Garufi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.